• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐碳青霉烯类革兰阴性杆菌(CRGNB)所致菌血症初始抗生素治疗不足相关的医疗资源利用及成本:一项西班牙医院的描述性观察研究

Healthcare resource utilization and costs associated with inadequate initial antibiotic treatment of bacteraemia produced by carbapenem-resistant Gram-negative bacilli (CRGNB): a descriptive, observational study in Spanish hospitals.

作者信息

Garnacho-Montero José, Aguado José María, Alemparte Enrique, Horcajada Juan P, López-Medrano Francisco, Ramírez Paula, Giró-Perafita Ariadna, Blasco Martí, Suberviola Borja

机构信息

Hospital Universitario Virgen del Rocío, Sevilla, Spain.

Unidad de Enfermedades Infecciosas, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.

出版信息

Rev Esp Quimioter. 2025 May 14;38(3):197-207. doi: 10.37201/req/121.2024. Epub 2025 Feb 25.

DOI:10.37201/req/121.2024
PMID:39998237
Abstract

INTRODUCTION

Carbapenem-resistant gram-negative bacilli (CRGNB) are one of the main causes of nosocomial infections, posing a major public health challenge. Blood stream infections (BSI) require special attention because of the higher morbidity and mortality associated.

OBJECTIVE

To assess the impact of initial adequate or inadequate antibiotic treatment on the length of stay (LOS) and healthcare resource utilisation of patients with bloodstream infections (BSI) caused by a Carbapenem-resistant gram-negative bacilli (CRGNB) in the Spanish clinical practice.

METHODS

A descriptive, observational, retrospective chart review study of patients diagnosed with CRGNB bacteriemia in 6 Spanish public hospitals.

RESULTS

The overall median LOS of the total population (n=64) was 26.5 days (Q1: 16 days; Q3: 40 days). The median LOS for the initially adequately treated group was 27 days (Q1: 17; Q3: 50), and 24 days (Q1: 15; Q3: 38) for the initially inadequately treated (t-test p= 0.5031). In the Hospital Ward group (n=44), initially adequately treated patients spent hospitalised a median of 6 days less than the initially inadequately treated patients (18 days [Q1: 12; Q3: 27] vs 24 days [Q1: 15; Q3: 38] respectively, p=0.0269). In the total population analysis, initially adequately treated patients had a lower use of resources (20,895.02 [Q1: 11,543.67 ; Q3: 61,773.17 ]) compared to initially inadequately treated patients (24,444.02 [Q1: 11,571.63 ; Q3: 40,790.64 ).

CONCLUSION

Results suggest that inadequate empirical treatment for BSI caused by CRGNB in the hospital ward could be associated with an increase in the LOS and resource utilization of these patients.

摘要

引言

耐碳青霉烯类革兰氏阴性杆菌(CRGNB)是医院感染的主要原因之一,构成了重大的公共卫生挑战。血流感染(BSI)因其较高的发病率和死亡率而需要特别关注。

目的

评估在西班牙临床实践中,初始抗生素治疗充分或不充分对耐碳青霉烯类革兰氏阴性杆菌(CRGNB)所致血流感染(BSI)患者住院时间(LOS)和医疗资源利用的影响。

方法

对西班牙6家公立医院中诊断为CRGNB菌血症的患者进行描述性、观察性、回顾性病历审查研究。

结果

总人群(n = 64)的总体中位住院时间为26.5天(第一四分位数:16天;第三四分位数:40天)。初始治疗充分组的中位住院时间为27天(第一四分位数:17天;第三四分位数:50天),初始治疗不充分组为24天(第一四分位数:15天;第三四分位数:38天)(t检验p = 0.5031)。在医院病房组(n = 44)中,初始治疗充分的患者住院时间比初始治疗不充分的患者中位数少6天(分别为18天[第一四分位数:12天;第三四分位数:27天]和24天[第一四分位数:15天;第三四分位数:38天],p = 0.0269)。在总人群分析中,初始治疗充分的患者与初始治疗不充分的患者相比,资源使用较低(分别为20,895.02[第一四分位数:11,543.67;第三四分位数:61,773.17]和24,444.02[第一四分位数:11,571.63;第三四分位数:40,790.64])。

结论

结果表明,医院病房中对CRGNB所致BSI进行经验性治疗不充分可能与这些患者的住院时间延长和资源利用增加有关。

相似文献

1
Healthcare resource utilization and costs associated with inadequate initial antibiotic treatment of bacteraemia produced by carbapenem-resistant Gram-negative bacilli (CRGNB): a descriptive, observational study in Spanish hospitals.耐碳青霉烯类革兰阴性杆菌(CRGNB)所致菌血症初始抗生素治疗不足相关的医疗资源利用及成本:一项西班牙医院的描述性观察研究
Rev Esp Quimioter. 2025 May 14;38(3):197-207. doi: 10.37201/req/121.2024. Epub 2025 Feb 25.
2
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.中性粒细胞减少患者中碳青霉烯类耐药的全球患病率及其与死亡率和碳青霉烯类使用的关联:系统评价和荟萃分析
J Antimicrob Chemother. 2017 Mar 1;72(3):668-677. doi: 10.1093/jac/dkw459.
3
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
4
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.氨曲南-阿维巴坦与美罗培南治疗革兰氏阴性菌引起的严重感染(再研究):一项描述性、多中心、开放标签、3期随机试验。
Lancet Infect Dis. 2025 Feb;25(2):218-230. doi: 10.1016/S1473-3099(24)00499-7. Epub 2024 Oct 7.
5
The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis.中低收入国家抗生素耐药菌导致的住院血流感染的影响:系统评价和荟萃分析。
PLoS Med. 2023 Jun 22;20(6):e1004199. doi: 10.1371/journal.pmed.1004199. eCollection 2023 Jun.
6
Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children.头孢他啶-阿维巴坦治疗肿瘤患儿多重耐药鲍曼不动杆菌感染的经验
Braz J Infect Dis. 2025 Mar-Apr;29(2):104515. doi: 10.1016/j.bjid.2025.104515. Epub 2025 Feb 21.
7
Carbapenem-resistant Gram-negative bacteria in urine of dogs rescued from Southern Brazil floods.从巴西南部洪水中获救的犬类尿液中的耐碳青霉烯革兰氏阴性菌。
Vet Res Commun. 2025 Jun 20;49(4):230. doi: 10.1007/s11259-025-10796-8.
8
Length of hospital stay and associated treatment costs for patients with susceptible and antibiotic-resistant infections: a systematic review and meta-analysis.易感感染和抗生素耐药感染患者的住院时间及相关治疗费用:一项系统评价和荟萃分析
BMJ Open. 2025 Jun 23;15(6):e092494. doi: 10.1136/bmjopen-2024-092494.
9
Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis.评估头孢他啶/阿维巴坦治疗革兰氏阴性菌感染的疗效和安全性:系统评价和荟萃分析。
Int J Antimicrob Agents. 2018 Oct;52(4):443-450. doi: 10.1016/j.ijantimicag.2018.07.004. Epub 2018 Aug 31.
10
Inadequate use of antibiotics and increase in neonatal sepsis caused by resistant bacteria related to health care assistance: a systematic review.抗生素使用不足以及与医疗保健相关的耐药菌引起的新生儿败血症增加:系统评价。
Braz J Infect Dis. 2018 Jul-Aug;22(4):328-337. doi: 10.1016/j.bjid.2018.07.009. Epub 2018 Aug 18.

本文引用的文献

1
Outcomes of inadequate empiric therapy and timing of newer antibacterial therapy in hospitalized adults with culture-positive Enterobacterales and Pseudomonas aeruginosa: a multicenter analysis.住院成人中培养阳性肠杆菌科和铜绿假单胞菌患者经验性抗菌治疗不足的结局和新型抗菌治疗时机:一项多中心分析。
BMC Infect Dis. 2024 Aug 9;24(1):810. doi: 10.1186/s12879-024-09700-7.
2
Hospital mortality and length of stay associated with positive blood cultures: a multicenter analysis.血培养阳性与医院死亡率及住院时间的相关性:一项多中心分析。
Microbiol Spectr. 2024 Aug 6;12(8):e0040224. doi: 10.1128/spectrum.00402-24. Epub 2024 Jul 2.
3
Disease burden of bacteraemia with extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in Korea.
韩国产超广谱β-内酰胺酶和耐碳青霉烯肠杆菌科细菌血症的疾病负担。
J Hosp Infect. 2024 Feb;144:85-93. doi: 10.1016/j.jhin.2023.11.013. Epub 2023 Dec 10.
4
Clinical Features and Outcomes of Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area.产金属β-内酰胺酶肠杆菌科细菌感染的临床特征和结局:来自流行地区的一项为期 3 年的前瞻性研究。
Clin Infect Dis. 2024 May 15;78(5):1111-1119. doi: 10.1093/cid/ciad725.
5
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health.抗菌药物耐药性:对全球公共卫生日益严重的威胁。
Healthcare (Basel). 2023 Jul 5;11(13):1946. doi: 10.3390/healthcare11131946.
6
Use of hospital resources in ICU inpatients with infections caused by carbapenem-resistant Gram-negative bacteria: A real clinical practice-based study in Spain.西班牙一项基于实际临床实践的研究:耐碳青霉烯类革兰氏阴性菌感染的重症监护病房住院患者的医院资源使用情况
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Mar;41(3):162-168. doi: 10.1016/j.eimce.2021.10.009. Epub 2023 Jan 5.
7
Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.血流感染和抗生素耐药模式:来自意大利南部的一项六年监测研究。
Pathog Glob Health. 2023 Jun;117(4):381-391. doi: 10.1080/20477724.2022.2129161. Epub 2022 Oct 3.
8
Antimicrobial Resistance and Its Spread Is a Global Threat.抗菌药物耐药性及其传播是一个全球性威胁。
Antibiotics (Basel). 2022 Aug 9;11(8):1082. doi: 10.3390/antibiotics11081082.
9
The problem of multi-resistance in gram-negative bacilli in intensive care units: Treatment and prevention strategies.重症监护病房革兰氏阴性杆菌多重耐药问题:治疗和预防策略。
Med Intensiva (Engl Ed). 2022 Jun;46(6):326-335. doi: 10.1016/j.medine.2022.04.006. Epub 2022 May 8.
10
Prevalence and Mortality Associated with Bloodstream Organisms: a Population-Wide Retrospective Cohort Study.血流感染病原体的流行率和死亡率:一项基于人群的回顾性队列研究。
J Clin Microbiol. 2022 Apr 20;60(4):e0242921. doi: 10.1128/jcm.02429-21. Epub 2022 Mar 7.